Author (Year) | Patients Controls | Material & Procedure | Results | p-value | Other |
---|---|---|---|---|---|
Michalsen (2005) [18] | 21 FMS 9 RA | Faeces Culture | No differences | n.s | pre- vs post-fasting |
14 FMS 7 RA | Faeces Culture | No differences | n.s | pre- vs post-MedDiet | |
Goebel (2008) [19] | 33 FMS17 CRPS 57 HC | Serum antibodies YersiniaorCampylobacter | FMS 27% positive CRPS 13% HC Not tested | NR | Trend for seropositivity assoc. with IP (Table 4) |
Minerbi (2019) [27] | 77 FMS 11 FC 20 HM 48 UC | Faeces 16S rRNA gene (V5-V6 region) / metagenome | ↓ Faecalibacterium and Bacteroides, ↑ Intestinimonas, Flavonifractor, Butyricoccus Eisenbergiella and Enterobacter. | < 0.01 | Non-significant differences in sample diversity Variance FMS vs UC |
Clos-Garcia (2019) [26] | 105 FMS 54 HC | Faeces 16S rDNA microbiome(V3–V4 region) | FMS: Absent families: Bifidobacteriaceae and Bacteroidales↑ Dorea, Roseburia, Alistipes, Papillibacter, Subdoligranulum↓ Bacteroides, Bifidobacterium, Eubacterium, Clostridium | All p ≤ 0.05 | Controls had higher diversity |